Wire · operational-macro
US FDA Hiring Binge Reversing Losses, But Only Slightly
◆ Sectors
Medtech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 7 September 2026 · Fusion42 review
The US FDA is increasing its hiring to reverse previous staff losses, but the recovery is only modest so far. This staffing trend may influence regulatory review speeds and resource availability for drug and device approvals.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
FDA staffing improvements ease some pressure on approval bottlenecks, but founders racing for faster clearance should prepare for continued delays and seek alternate paths to market.
◆ Coverage
1 source · 7 Sep 2026
◆ Related on Wire
◆ Topics
Medtechfdastaffingregulatory-speedmedtech